Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
To investigate the therapy effect and security of oxaliplatin and fluorouracil on with or
without concomitant vascular invasion and extrahepatic metastases unresectable advanced
primary liver cancer